Daytime Light Exposure for Insomnia in Critically Ill Children
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore new methods to help critically ill children aged 3 to 6 sleep better in the hospital. Researchers will examine whether exposing children to bright light during the day (daytime light exposure) and providing food only during typical waking hours (daytime restricted feeding) can enhance their sleep and body clock rhythms. The trial will test these methods by first monitoring current sleep patterns and then implementing the light exposure and feeding schedule in different groups. Children admitted to the pediatric intensive care unit (PICU) and expected to stay for more than a day may be suitable candidates for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve hospital care for children.
Do I need to stop my child's current medications for the trial?
The trial information does not specify whether your child needs to stop taking current medications. It's best to discuss this with the trial coordinators.
What prior data suggests that daytime light exposure and daytime restricted feeding are safe for critically ill children?
Research has shown that exposure to daylight during the day is generally safe and can improve sleep quality. For example, one study found that office workers who received more daylight felt better and slept better. Although little information exists on how daylight affects children in hospitals, no harm has been reported in these settings.
Regarding eating only during the day, the evidence remains unclear. Some studies suggest it might aid metabolism and improve how sick children handle food. However, concerns exist about its impact on nutrition. While no strong evidence of harm has emerged, more research is necessary.
Overall, both treatments appear well-tolerated, but information is limited, particularly concerning restricted feeding in children.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative non-pharmacological approaches to manage insomnia in critically ill children. Unlike standard care options, which often involve medications to aid sleep, this trial investigates the effects of daytime light exposure and restricted feeding schedules. Daytime light exposure uses a light box to potentially reset the circadian rhythm, while restricted feeding aligns nutritional intake with the child's natural wake hours to support better sleep patterns. These methods could offer safer, drug-free alternatives to improve sleep in young patients, which is why researchers are eager to see the outcomes.
What evidence suggests that this trial's treatments could be effective for insomnia in critically ill children?
Research shows that enough daylight can improve sleep in seriously ill children by adjusting their body clocks. In this trial, one group of children will receive daytime light exposure, with bright light during the day. Studies have found this can lead to less disrupted sleep and better sleep quality, which has been linked to improved brain function in children.
Another group will undergo daytime restricted feeding. Studies suggest that regular meals when children are naturally awake can support better body rhythms, potentially improving sleep. Research indicates that eating at set times might stabilize blood sugar levels and lower infection risk in seriously ill patients. Both treatments in this trial aim to enhance sleep and overall health in children during serious illness.16789Are You a Good Fit for This Trial?
This trial is for critically ill children aged 3 to 6 who are admitted to the Pediatric Intensive Care Unit (PICU) and expected to stay at least 24-48 hours. A parent who speaks English must be present. It's not specified who can't join, but typically those with conditions affecting sleep or circadian rhythms might be excluded.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Standard of Care
Participants receive routine critical care while feasibility of sleep and circadian rhythm measurement is assessed using actigraphy and salivary melatonin samples
Daytime Light Exposure
Participants receive timed exposure to a light box of 10,000 lux for PICU days #2, 3, and 4 while undergoing sleep monitoring and salivary melatonin sampling
Daytime Restricted Feeding
Participants have all nutrition restricted to daytime hours for PICU days #2, 3, and 4 while undergoing sleep monitoring and salivary melatonin sampling
Follow-up
Participants are monitored for safety and effectiveness after interventions
What Are the Treatments Tested in This Trial?
Interventions
- Daytime light exposure
- Daytime restricted feeding
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor